Cabeza Montilla, Laura Author
Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(?-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study
- Cabeza L.
- Ortiz R.
- Prados J.
- Delgado Á.
- Martín-Villena M.
- Clares B.
- Perazzoli G.
- Entrena J.
- Melguizo C.
- Arias J.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES - 1/5/2017
- SJR Quartile: Q1
- JCR Impact Factor: 3.466 (2017)
- CiteScore: 7.8 (2020)
- SJR: 1.016 (2017
- SNIP: 1.319 (2017
- JCR 5-year Impact Factor: 3.869
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
DNA methylation patterns as molecular biomarkers: An overview in colorectal cancer
- González-Flores E.
- Hernández R.
- Álvarez P.
- Cabeza L.
- Perazzoli G.
- Zafra I.
- Melguizo C.
- Prados J.
- Rama A.
European Journal of Anatomy - 1/7/2018
- SJR Quartile: Q3
- CiteScore: 0.5 (2020)
- SJR: 0.174 (2018
- SNIP: 0.289 (2018
- SJR Categories: Anatomy (Q3)
- Dialnet
- Scopus
- ORCID
- Web of Science
Gastrointestinal stromal tumours: An actualized overview
- Gonzalez B.
- Leiva M.
- Alvarez P.
- Perazzoli G.
- Cabeza L.
- Jiménez-López J.
- Doello K.
- Prados J.
- Melguizo C.
- Ortiz R.
European Journal of Anatomy - 1/1/2017
- SJR Quartile: Q4
- CiteScore: 0.5 (2020)
- SJR: 0.157 (2017
- SNIP: 0.218 (2017
- SJR Categories: Anatomy (Q4)
- Dialnet
- Scopus
- ORCID
- Web of Science
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles
Drug Design Development and Therapy - 14/12/2015
- SJR Quartile: Q1
- JCR Impact Factor: 2.881 (2015)
- CiteScore: 3.27 (2018)
- SJR: 0.982 (2015
- SNIP: 0.978 (2015
- JCR 5-year Impact Factor: 2.962
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)
- Scopus
- ORCID
- Web of Science
Nanomedical Platform for Drug Delivery in Cancer
- Ortiz, Raul
- Cabeza, Laura
- Leiva, Maria C.
- Jimenez-Lopez, Julia
- Melguizo, Consolacion
- Prados, Jose
Current Organic Chemistry - 28/11/2017
10.2174/2213337203666161018121920 View source
- SJR Quartile: Q3
- JCR Impact Factor: 2.193 (2017)
- JCR 5-year Impact Factor: 1.923
- JCR Categories: CHEMISTRY, ORGANIC
- SJR Categories: Organic Chemistry (Q3)
- ORCID
- Web of Science
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
- Ortiz R.
- Perazzoli G.
- Cabeza L.
- Jiménez-Luna C.
- Luque R.
- Prados J.
- Melguizo C.
Current Neuropharmacology - 1/1/2021
10.2174/1570159x18666200626204005
- JCR Quartile: Q1 (2021)
- JCR Impact Factor: 7.708 (2022)
- Category normalized Impact: 2.561 (2021)
- CiteScore: 10.5 (2020)
- SJR: 1.955 (2020
- SNIP: 1.851 (2020
- JCR 5-year Impact Factor: 9.589
- JCR Categories: NEUROSCIENCES
- Scopus
- ORCID
- Web of Science
Last advances in nanocarriers-based drug delivery systems for colorectal cancer
- Rama A.
- Jimenez-Lopez J.
- Cabeza L.
- Jimenez-Luna C.
- Leiva M.
- Perazzoli G.
- Hernandez R.
- Zafra I.
- Ortiz R.
- Melguizo C.
- Prados J.
Current Drug Delivery - 1/9/2016
10.2174/1567201813666151203232852
- SJR Quartile: Q2
- JCR Impact Factor: 2.516 (2016)
- CiteScore: 3.6 (2020)
- SJR: 0.504 (2016
- SNIP: 0.747 (2016
- JCR 5-year Impact Factor: 2.338
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q2)
- Scopus
- ORCID
- Web of Science
Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy
- Lorente C.
- Cabeza L.
- Clares B.
- Ortiz R.
- Halbaut L.
- Delgado Á.
- Perazzoli G.
- Prados J.
- Arias J.
- Melguizo C.
COLLOIDS AND SURFACES B-BIOINTERFACES - 1/11/2018
10.1016/j.colsurfb.2018.07.070
- SJR Quartile: Q1
- JCR Impact Factor: 3.973 (2018)
- CiteScore: 8.2 (2020)
- SJR: 0.957 (2018
- SNIP: 1.065 (2018
- JCR 5-year Impact Factor: 4.18
- JCR Categories: MATERIALS SCIENCE, BIOMATERIALS
- SJR Categories: Medicine (miscellaneous) (Q1); Surfaces and Interfaces (Q1); Biotechnology (Q2); Colloid and Surface Chemistry (Q2); Physical and Theoretical Chemistry (Q2)
- Scopus
- ORCID
- Web of Science
The antitumor activity of sodium selenite alone and in combination with gemcitabine in pancreatic cancer: An in vitro and in vivo study
- Doello K.
- Mesas C.
- Quiñonero F.
- Perazzoli G.
- Cabeza L.
- Prados J.
- Melguizo C.
- Ortiz R.
Cancers - 1/7/2021
- JCR Quartile: Q1 (2021)
- JCR Impact Factor: 6.575 (2022)
- Category normalized Impact: 0.828 (2021)
- JCR 5-year Impact Factor: 6.886
- JCR Categories: ONCOLOGY
- Scopus
- ORCID
- Web of Science
Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
- Raúl Ortíz
- Francisco Quiñonero
- Beatriz García-Pinel
- Marco Fuel Herrera
- Cristina Mesas
- Laura Cabeza
- Consolación Melguizo Alonso
- Jose Prados
Cancers - 1/04/2021
- JCR Impact Factor: 6.575 (2021)
- JCR 5-year Impact Factor: 6.886
- JCR Categories: ONCOLOGY
- Scopus
- ORCID
- Web of Science
Efectos del trabajo a turnos en enfermeras del servicio de urgencias hospitalarias entre 55 y 65 años en las etapas menopausia y post-menopausia
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Investigación en salud y envejecimiento: Volumen VI - 2019
- Dialnet
Combinaciones terapéuticas y sus ventajas en el tratamiento del síndrome de dolor miofascial
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Acercamiento multidisciplinar a la salud: Volumen IV - 2019
- Dialnet
Mejora de la actividad antitumoral de agentes citotóxicos mediante el uso de nanoplataformas poliméricas: aplicación en cáncer de colon, mama y pulmón
- Laura Cabeza
- Consolación Melguizo
- José Carlos Prados Salazar
- Raul Ortiz Quesada
2017
- Dialnet
This author has no conferences.
This author has no patents.
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
h index
Scopus: 13
Web of Science: 21
i10 index
Scopus: 19
Web of Science: 30
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador